Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know they've stated that it was built to UL specifications, but I don't recall if they ever announced it had been UL approved.
10-K is out.
BOMBZ AWAY!!!! Sub-penny here it comes.
I have only seen it rise after the release of financials once, and that was the release of the Q2 financials in August of 2010. Every other time that I can remember the posting of financial statements resulted in a decline in PPS, even if it rebounded later. Obviously the past is not necessarily reflective of future results, but take it for what it's worth.
That last 749,100 buy evened up the score some, but that buy was when the ask had dropped to .0087. So, while the data may not appear to show heavy selling today, almost all of the volume has been below .009. That's not a good sign.
An AS cap is meaningless when management has the authority to raise it at-will. It might as well be listed as unlimited because without the requirement of a shareholder vote, it is for all intents and purposes unlimited. Lowering the cap is nothing but a dog and pony show.
It's a sad, sad day for the relaxation beverage "industry". Purple Stuff is no longer available at my local 7Eleven. Luckily, Drank is still stocked on the off chance that I ever feel the need to fall asleep at the wheel. Still no sign of the self proclaimed leader of the relaxation beverage industry. Not a Koma to be found anywhere.
Have any of you that talk directly to the CEO asked for an updated on the financials? Or the form 10 that they PRd 2 months ago?
How long ago was this reply? Locin Industries was the distributor back in 2008, and the last Canadian distributor that I remember hearing PR'd was Northern Response.
There never was a March 31 decision date. That date was made up by Biomedreports, a penny pumping website, and was pure speculation.
Strike that. I found their webpage.
http://www.northlandfulfillment.com/
I have studied all of the available information including the financial statements, PRs, and other public filings. I do not consider calling the CEO of a pink sheet traded company to be due diligence especially when information obtained from that source in the past has proven to be less than accurate. The information I have provided on this board is based on verifiable facts provided by the company, and my opinion derived from my analysis of that information. I believe that is the purpose of these boards. Good luck to you.
Please do not make things up and speculate.
BIEL is ready to set a major distributor in place in Canada...soon. BIEL is ready and are making sure they have picked the right distributor who has the money and experience to move product thru the chains. They have done that,and should announce soon.
I challenge you to find me one other company in the WORLD that realizes 90% net income because I am going to drop my life savings into that company. You're being completely unrealistic. First of all, your estimate of $1 per patch to produce is wrong as the financials indicate it's closer to $4 a patch. Secondly, in order to realize revenue that high you would need to hire more employees, increase marketing expenses, rent more space to house all of the new employees, pay taxes, etc...
I understand that you have a positive outlook on the company, and that's great, but you have to insert some common sense at some point. Good luck.
Maybe they're tearing it up and raking in the money from the TV campaigns, but I won't believe that until I see it show up on a quarterly filing. I simply don't believe that this model is sustainable long-term unless they intend to go 100% direct-to-consumer. If so, then revenues will be lower than being available in-store, but they should also be able to control expenses and realize higher gross margins. Either model can work, but they need to pick one and stick with it, in my opinion.
That was back when BIEL had a Canadian distributor, which they no longer do. There is a reason that the manufacturer-distributor-retailer model exists and is used by the overwhelming majority of businesses, and that's because it WORKS. It is incredibly inefficient for a company the size of BIEL to try and distribute their own products to retailers. Online, sure no problem, but placing them in brick and mortar stores simply requires to much time and too many resources. Distributors already have those relationships and contracts in place. BIEL bringing their distribution in-house wasn't a choice, in my opinion, it was an act of desperation. If they are able to find a strong distribution partner in Canada, or the U.S. if FDA approval does indeed happen, then they will. I guess I should put the IMO disclaimer here, so, IMO.
I said it was bad for current shareholders, not the company.
Well, obviously my opinion differs from yours. I expect Q4 revenues to be $250k or less. If you look at prior years, 4th quarters have not been good for the company, unless you count the bill and hold transactions from 2009, which I don't. I am 99.99% positive that they will not show an operating profit for Q4.
I expect Q1 numbers to be better, but not great.
The warrants are the killer. St. George received warrants which will allow them to purchase $600k worth of stock at a price equal to 70% of the average 3 lowest closing prices during the 20 days prior to 3/31. That would be .036, .037, and .037 which would mean a conversion price of 0.257. That means if this thing does run, then they will convert and drop an additional 23+ million shares on the market. This would be good for CSKH, as it would mean additional capital, but bad for current shareholders.
If you look up in the Ibox you'll see the notice from Nov 10 when they increased the AS to 1.75 billion shares and inferred that they would be issuing those shares sooner rather than later. My number was operating under the assumption that sometime between now and the final(?) FDA decision they will be forced to dilute again due to their lack of positive cash flow.
Except that you're confusing gross margin with net income. Expanding their business would result in increased overhead, taxes, etc... I gave them a very, very favorable net margin of 20% in my previous post, while in reality it would probably be significantly less than that.
Yes, I know this is pinkie land, and they are more volatile than exchange traded stocks, but a 10,000% increase is beyond the limits of even the pump & dump artists to achieve on a stock already trading above a penny. You'll occassionally see it in a stock that goes from .0001 to a penny, but that's a completely different scenario.
And at a P/E ration of 15, they would need over 100 million in net income, which sales would probably need to be $500 million or more.
$1? So you think that FDA approval, without any evidence that there is a significant market for the product, would convince the market that BIEL is worth $2 billion?? At what point do you add a dose of reality into your projections?
I might, except that if I ever actually have the urge to try a nasty grape Kool aid flavored relaxation drink I'll just mosey on down to the 7-eleven and buy the one that Koma copied, Drank. Or Purple Stuff, since that's available at 7-eleven as well.
Disregard, I apparently missed the PR this morning about the new site.
No axe to grind. Following pinkies is entertainment for me. If I am able to help out some people along the way then that's a bonus. I enjoy the debate and doing the research, but I don't have the desire to put any money into them. And you're right, I have never and will never buy or sell any shares of any of these companies. Good luck.
Companies like Global Newswire, who issued the release, aren't in the business of rewriting press releases. They are paid to send out the information as it is provided to them by the company or PR firm. In this case, the Source is listed as YESDTC Holdings, Inc. and there is no doubt in my mind that it was authored by the CEO of YESD himself.
Believe what you want, but given the information at hand, I see no reason to doubt the validity of the PR and therefore I stand firm in what I believe the current OS to be, and that is close to 360 million shares.
http://www.globenewswire.com/newsroom/news.html?d=217914
I don't know how you can read it any other way.
The title states:
YesDTC and Medical Alarm Concepts Create Joint Marketing Venture -- YesDTC Acquires 6.0% Stake in Company
Additionally, YesDTC has acquired approximately 21.5 million shares of Medical Alarm Holdings, Inc. as part of the agreement.
Pretty simple math. The PR states that he acquired about 21.5 million shares, or a 6.0% "stake in company".
21,500,000/.06 = 358,333,333
Also of note, assuming the information in the PR is correct, then the current OS has increased to 358+ million, or over 40 million shares since they issued their 10Q.
I think it hurts MDHI's credibility to enter into a JMV with a penny stock promoter who has been known to impersonate women on message boards in order to sell product.
http://www.wellness.com/forum/forum_posts.asp?TID=911&PN=9&TPN=2
Maybe it will work out well for them, but if you check out the performance of other stocks in which their partner has been involved with over the last couple years it doesn't bode well.
It will be lucky to hold $.025 after this release. It's one thing to miss revenue guidance by 20%, or to revise it down throughout the year. It's a whole other animal when the CEO confirms $15+ million in revenue as late as October of last year and you miss it by 67%. Not notifying shareholders prior to today is negligent at best, criminal at worst, in my opinion.
There's not going to be any R/S before two audited quarters ! You guy's can talk all day about it but it's not going to happen
I would stick to the scratch off lottery tickets. You have a much higher chance of winning on those than you do sinking your money into this share selling scam.
That's because the filer, YESD's top-notch CEO, copied and pasted from his last NT 10-Q and submitted it without proofreading it first. I mean, it's only an offical SEC filing, why bother taking 30 seconds to ensure accuracy?
One problem with that concept and that's the fact that it would be ILLEGAL for him to market the product for any indication for which it has not been approved by the FDA. To date, Actipatch has ONLY been approved for treatment of swelling following eye surgery, by prescription only. Taking a trip around the country to market it for any other purpose would land him with heavy fines and possibly jail time.
That's one of the big differences between owning shares of a pinksheet company versus an exchange traded company. On an exchange traded company, management reports to a board that is required to be made up of over 50% of independent directors. The board acts on behalf of the shareholders, and if management isn't performing in the shareholder's best interests then they have the power to make changes to the management structure.
In a company like BIEL, there are no independent directors. Management IS the board of directors, and their bylaws allow them to do whatever they want, with or without shareholder approval. It's a risk you have to take into account when conducting your DD on non exchange traded stocks.
1) Great, now deliver on the no later than date. I am curious as to whether or not the new CPA will require them to restate the bill and hold transactions from 2009.
2) Again, this is great, but they need to produce results. They have been through literally dozens of distributors in the past and sales have not taken off.
3) Unfortunately we have heard the "FDA is close to making a decision" for years now. Stop talking about it and make it happen.
4) Hopefully this new product will gain faster approval than the PEMF line and will be a good source of revenue.
5) This is where things always start to go off-track. Why even say something like this? If "Major Pharma" was truly interested then they would have put a NDA in place with BIEL. There is no point in even making this statement aside from trying to pump up the PPS. When you have entered into serious discussions then make this announcement. Until the, it smacks of penny pumping.
6) Hopefully they place an order. 15,000 units? Isn't that the exact number of units Joe Noel ordered in the bill and hold transaction and never took delivery of?
7) BIEL is not generating enough revenue to fund operations. When they say the have "enough money" that means that they have entered into additional finance arrangements which will likely result in dilution. We'll see exactly what he means by enough money when the financial statements are released.
Good luck.
So, to recap...
1) Not one mention of the company or the product anywhere on the car.
2) The few misguided folks who tried to support their driver by purchasing the giftpack got screwed with shipping charges.
Does that about cover it?
Am I the only one that noticed that their disappearances coincide?